{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:52:41Z","timestamp":1794858761575,"version":"4.9.1"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Our group and others have recently identified four molecular groups of meningioma, with unique underlying biology and outcomes. The relevance of group-specific metabolite profiles (particularly among hypermetabolic tumors), has not been explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed untargeted metabolic profiling of meningiomas representing each molecular group and World Health Organization (WHO) grade. Prognostic biochemicals were identified using Cox regression and their biological importance was explored using RNA and protein-based pathway analyses. Validation was performed using targeted high performance liquid chromatography-mass spectrometry (HPLC-MS\/MS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Global metabolic profiling identified 560 unique biochemicals. We identified a 21-metabolite outcome signature which is strongly predictive of outcome after adjusting for WHO grade, extent of resection, and receipt of adjuvant radiotherapy (HR\u2005=\u2005326.49, 95% CI\u2005=\u200516.72-6375.48, P\u2005&amp;lt;\u2005.0001). The abundance of N6-trimethyllysine was associated with earlier time to recurrence on our whole cohort (log-rank P\u2005=\u2005.009) and within hypermetabolic and WHO grade 2 tumors specifically; this was validated using targeted HPLC-MS\/MS on two cohorts. Consensus RNA and protein expression analysis demonstrated as association between N6-trimethyllysine abundance and activation of oxidative phosphorylation pathways, which portended worse outcomes in the hypermetabolic subgroup but, interestingly, better outcomes in the proliferative subgroup. By contrast, upregulated pyruvate and lactate transporters were associated with worse outcomes in proliferative meningiomas specifically.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This is the first study to demonstrate a subgroup-specific prognostic role of N6-trimethyllysine in hypermetabolic meningiomas, offering increasingly granular outcome predictions using a widely accessible technique (HPLC-MS\/MS). We also suggest fundamental differences in preferred energy utilization between and a potential need for subgroup-specific therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noae281","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T15:21:33Z","timestamp":1737645693000},"page":"2047-2059","source":"Crossref","is-referenced-by-count":6,"title":["Metabolic profiling of meningioma reveals novel subgroup-specific biologic insights and outcome dependencies"],"prefix":"10.1093","volume":"27","author":[{"given":"Alexander P","family":"Landry","sequence":"first","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, ON ,","place":["Canada"]},{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto , Toronto, ON ,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin Z","family":"Wang","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, ON ,","place":["Canada"]},{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto , Toronto, ON ,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leeor S","family":"Yefet","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, ON ,","place":["Canada"]},{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto , Toronto, ON ,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Liu","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, ON ,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Patil","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, ON ,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Sosa","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, ON ,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Ellenbogen","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, ON ,","place":["Canada"]},{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto , Toronto, ON ,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Gui","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, ON ,","place":["Canada"]},{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto , Toronto, ON ,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ajisebutu","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, ON ,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5119-7550","authenticated-orcid":false,"given":"Kenneth","family":"Aldape","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute , Bethesda, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gao","sequence":"additional","affiliation":[{"name":"Division of Laboratory Medicine and Pathobiology, University Health Network , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kislinger","sequence":"additional","affiliation":[{"name":"Department of Medical Biophysics, University of Toronto , Toronto ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4581-8848","authenticated-orcid":false,"given":"Eric X","family":"Chen","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Nassiri","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, ON ,","place":["Canada"]},{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto , Toronto, ON ,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6637-4502","authenticated-orcid":false,"given":"Gelareh","family":"Zadeh","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, ON ,","place":["Canada"]},{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto , Toronto, ON ,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"issue":"Suppl 5","key":"2025091918571323200_CIT0001","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015\u20132019","volume":"24","author":"Ostrom","year":"2022","journal-title":"Neuro Oncol"},{"issue":"5","key":"2025091918571323200_CIT0002","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol."},{"issue":"7","key":"2025091918571323200_CIT0003","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/neuonc\/noz061","article-title":"DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management","volume":"21","author":"Nassiri","year":"2019","journal-title":"Neuro Oncol"},{"issue":"10","key":"2025091918571323200_CIT0004","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/neuonc\/noae082","article-title":"Meningioma: International Consortium on Meningiomas (ICOM) consensus review on scientific advances & treatment paradigms for clinicians, researchers, and patients","volume":"26","author":"Wang","year":"2024","journal-title":"Neuro Oncol"},{"issue":"7874","key":"2025091918571323200_CIT0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","article-title":"A clinically applicable integrative molecular classification of meningiomas","volume":"597","author":"Nassiri","year":"2021","journal-title":"Nature."},{"issue":"5","key":"2025091918571323200_CIT0006","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41588-022-01061-8","article-title":"Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities","volume":"54","author":"Choudhury","year":"2022","journal-title":"Nat Genet."},{"issue":"5","key":"2025091918571323200_CIT0007","doi-asserted-by":"crossref","first-page":"eabm6247","DOI":"10.1126\/sciadv.abm6247","article-title":"Multiple approaches converge on three biological subtypes of meningioma and extract new insights from published studies","volume":"8","author":"Bayley","year":"2022","journal-title":"Sci Adv."},{"issue":"Supplement_7","key":"2025091918571323200_CIT0008","doi-asserted-by":"crossref","first-page":"vii158","DOI":"10.1093\/neuonc\/noac209.608","article-title":"Path-35. Hypermitotic meningiomas harbor dna methylation subgroups with distinct biological and clinical features","volume":"24","author":"Choudhury","year":"2022","journal-title":"Neuro-Oncology."},{"issue":"11","key":"2025091918571323200_CIT0009","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1038\/s41591-024-03167-4","article-title":"Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma","volume":"30","author":"Wang","year":"2024","journal-title":"Nat Med."},{"issue":"22","key":"2025091918571323200_CIT0010","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1158\/0008-5472.CAN-12-1572-T","article-title":"The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism","volume":"72","author":"Chinnaiyan","year":"2012","journal-title":"Cancer Res."},{"issue":"16","key":"2025091918571323200_CIT0011","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1021\/ac901536h","article-title":"Integrated, nontargeted ultrahigh performance liquid chromatography\/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems","volume":"81","author":"Evans","year":"2009","journal-title":"Anal Chem."},{"issue":"1","key":"2025091918571323200_CIT0012","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics."},{"issue":"16","key":"2025091918571323200_CIT0013","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics."},{"issue":"8","key":"2025091918571323200_CIT0014","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkz114","article-title":"The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2025091918571323200_CIT0015","first-page":"e47","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume-title":"Nucleic Acids Res","author":"Ritchie","year":"2015"},{"key":"2025091918571323200_CIT0016","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling Survival Data: Extending the Cox Model","author":"Therneau","year":"2000"},{"key":"2025091918571323200_CIT0017","doi-asserted-by":"publisher","DOI":"10.1038\/sj.hdy.6800737","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Development Core Team","year":"2016"},{"issue":"1","key":"2025091918571323200_CIT0018","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12859-017-1559-2","article-title":"Reactome pathway analysis: a high-performance in-memory approach","volume":"18","author":"Fabregat","year":"2017","journal-title":"BMC Bioinf."},{"issue":"1","key":"2025091918571323200_CIT0019","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."},{"issue":"7","key":"2025091918571323200_CIT0020","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.neo.2019.04.007","article-title":"Determination of Pyruvate metabolic fates modulates head and neck tumorigenesis","volume":"21","author":"Chen","year":"2019","journal-title":"Neoplasia"},{"issue":"3","key":"2025091918571323200_CIT0021","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.tibs.2016.01.002","article-title":"Pyruvate and metabolic flexibility: illuminating a path toward selective cancer therapies","volume":"41","author":"Olson","year":"2016","journal-title":"Trends Biochem Sci."},{"issue":"10","key":"2025091918571323200_CIT0022","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1158\/1535-7163.MCT-19-0079","article-title":"Metabolic flexibility in cancer: targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase axis","volume":"18","author":"Woolbright","year":"2019","journal-title":"Mol Cancer Ther."},{"issue":"7750","key":"2025091918571323200_CIT0023","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41586-019-0977-x","article-title":"Breast cancer cells rely on environmental pyruvate to shape the metastatic niche","volume":"568","author":"Elia","year":"2019","journal-title":"Nature."},{"issue":"1","key":"2025091918571323200_CIT0024","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1373\/clinchem.2015.248146","article-title":"Effective use of mass spectrometry in the clinical laboratory","volume":"62","author":"Jannetto","year":"2016","journal-title":"Clin Chem."},{"issue":"23","key":"2025091918571323200_CIT0025","doi-asserted-by":"crossref","first-page":"16697","DOI":"10.3390\/ijms242316697","article-title":"Identification of metabolomic markers in frozen or formalin-fixed and paraffin-embedded samples of diffuse glioma from adults","volume":"24","author":"Chardin","year":"2023","journal-title":"Int J Mol Sci."},{"issue":"6","key":"2025091918571323200_CIT0026","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1158\/1541-7786.MCR-19-1091","article-title":"Metabolic profiling of formalin-fixed paraffin-embedded tissues discriminates normal colon from colorectal cancer","volume":"18","author":"Arima","year":"2020","journal-title":"Mol Cancer Res"},{"issue":"1","key":"2025091918571323200_CIT0027","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41419-024-06435-w","article-title":"Amino acid metabolism in tumor biology and therapy","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis."},{"issue":"24","key":"2025091918571323200_CIT0028","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.3390\/ijms21249451","article-title":"Trimethyllysine: from carnitine biosynthesis to epigenetics","volume":"21","author":"Maas","year":"2020","journal-title":"Int J Mol Sci."},{"issue":"2","key":"2025091918571323200_CIT0029","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41419-018-0313-7","article-title":"The carnitine system and cancer metabolic plasticity","volume":"9","author":"Melone","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"2025091918571323200_CIT0030","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13148-019-0776-0","article-title":"The timeline of epigenetic drug discovery: from reality to dreams","volume":"11","author":"Ganesan","year":"2019","journal-title":"Clin Epigenetics"},{"issue":"1","key":"2025091918571323200_CIT0031","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2020.12.020","article-title":"Metabolic adaptation in hypoxia and cancer","volume":"502","author":"Paredes","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"2025091918571323200_CIT0032","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1021\/acs.jproteome.9b00521","article-title":"Metabolomic profile of aggressive meningiomas by using high-resolution magic angle spinning nuclear magnetic resonance","volume":"19","author":"Bender","year":"2020","journal-title":"J Proteome Res."},{"issue":"1","key":"2025091918571323200_CIT0033","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12885-021-07887-5","article-title":"Metabolic alterations in meningioma reflect the clinical course","volume":"21","author":"Masalha","year":"2021","journal-title":"BMC Cancer"},{"issue":"2","key":"2025091918571323200_CIT0034","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/neuonc\/nov105","article-title":"Alterations of oxidative phosphorylation in meningiomas and peripheral nerve sheath tumors","volume":"18","author":"Feichtinger","year":"2016","journal-title":"Neuro Oncol"},{"issue":"2","key":"2025091918571323200_CIT0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/B:NEON.0000003680.84840.52","article-title":"Metabolic patterns in meningiomas","volume":"65","author":"Herting","year":"2003","journal-title":"J Neurooncol."},{"issue":"7","key":"2025091918571323200_CIT0036","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1515\/hsz-2020-0376","article-title":"Glycation of benign meningioma cells leads to increased invasion","volume":"402","author":"Selke","year":"2021","journal-title":"Biol Chem."},{"issue":"6","key":"2025091918571323200_CIT0037","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41416-023-02394-9","article-title":"Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities","volume":"129","author":"Machado","year":"2023","journal-title":"Br J Cancer."},{"issue":"8","key":"2025091918571323200_CIT0038","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/aps.2016.47","article-title":"Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect","volume":"37","author":"Chen","year":"2016","journal-title":"Acta Pharmacol Sin."},{"issue":"1","key":"2025091918571323200_CIT0039","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/1078-0432.CCR-06-1377","article-title":"Expression of the Hypoxia Marker Carbonic Anhydrase 9 Is Associated with Anaplastic Phenotypes in Meningiomas","volume":"13","author":"Yoo","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2025091918571323200_CIT0040","doi-asserted-by":"crossref","first-page":"170","DOI":"10.15386\/mpr-2059","article-title":"HIF 1 \u0251 \u2013 a promising target for the treatment of meningiomas","volume":"96","author":"Butta","year":"2023","journal-title":"Med Pharm Rep"},{"issue":"1","key":"2025091918571323200_CIT0041","doi-asserted-by":"crossref","first-page":"14115","DOI":"10.1038\/s41598-020-70514-z","article-title":"Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression","volume":"10","author":"Karimi","year":"2020","journal-title":"Sci Rep."},{"issue":"1","key":"2025091918571323200_CIT0042","doi-asserted-by":"crossref","first-page":"156535","DOI":"10.1016\/j.cyto.2024.156535","article-title":"A gain of function mutation in AKT1 increases hexokinase 2 and diminishes oxidative stress in meningioma","volume":"176","author":"Singh","year":"2024","journal-title":"Cytokine."},{"issue":"11","key":"2025091918571323200_CIT0043","doi-asserted-by":"crossref","first-page":"e0207612","DOI":"10.1371\/journal.pone.0207612","article-title":"Preoperative grading of intracranial meningioma by magnetic resonance spectroscopy (1H-MRS)","volume":"13","author":"Lin","year":"2018","journal-title":"PLoS One."},{"issue":"1","key":"2025091918571323200_CIT0044","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1179\/174313206X153824","article-title":"MR spectroscopy in patients with intracranial meningiomas","volume":"29","author":"Buhl","year":"2007","journal-title":"Neurol Res."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noae281\/61618885\/noae281.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/27\/8\/2047\/61618885\/noae281.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/27\/8\/2047\/61618885\/noae281.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T22:57:22Z","timestamp":1758322642000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/27\/8\/2047\/7978626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,1,24]]},"published-print":{"date-parts":[[2025,9,17]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noae281","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,1,24]]}}}